New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2014
08:39 EDTCMRXChimerix shares remain undervalued, says Cowen
Cowen believes shares of Chimerix remain undervalued following its dinner management. The firm remains confident its SUPPRESS trial for brincidofovir will succeed in 2015 and expects other opportunities for the drug to materialize in 2014. Shares are Outperform rated with a $27 price target.
News For CMRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 17, 2015
10:14 EDTCMRXChimerix management to meet with Piper Jaffray
Subscribe for More Information
April 15, 2015
08:48 EDTCMRXChimerix should 'easily' win BARDA smallpox contract, says Brean Capital
Subscribe for More Information
April 14, 2015
11:34 EDTCMRXChimerix HHS contract shows applicability of brin, says Piper Jaffray
Subscribe for More Information
10:16 EDTCMRXHigh option volume stocks
High option volume stocks: NSAM ALU CJES BIG CMRX ERIC NTAP TMO KN CIG
10:02 EDTCMRXChimerix awarded HHS smallpox contract worth $100M, $435M with options
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use